Unlike many here that change their tune weekly and sometimes daily.... "we're gonna crash! we're gonna rally!" ---- Real market pros stay resolute and unwavering in their predictions.
--Kahoot initiated with an Overweight at Morgan Stanley --AgileThought initiated with a Buy at Needham 07:25 AGIL Needham analyst Mayand Tandon initiated coverage of AgileThought with a Buy rating and $7.00 price target. The analyst is positive on the company's position as an emerging digital services provider with a delivery footprint in Latin America, also noting that its enterprise value to expected revenue multiple of 1.25-times his FY23 estimate represents a deep discount to its closest pure-play digital transformation peers. Tandon further notes that AgileThought's balance sheet health is quickly improving, and he believes that its discounted valuation creates an attractive entry point. Show --Clearside Biomedical's SCS platform featured in presentations at AAO meeting 07:21 CLSD, BUY CLSD-$1.19
Van I remember exactly what you said Big rally starting on Sept 15, I put a bunch of money in and lost everything! When the HF asked why I was buying I said " Van said a big rally " Time for you to step back sit down and watch me roll! Once again this is MY RALLY!
8/9- Clearside Biomedical jumps following financing pact with HealthCare Royalty 08/09 CLSD Shares of Clearside Biomedical (CLSD) are on the rise on Tuesday after the company announced a non-dilutive financing agreement with HealthCare Royalty, supporting progression of CLS-AX clinical program. Alongside its second quarter results, Clearside Biomedical said it had entered into a Royalty Interest Purchase and Sale Agreement with HealthCare Royalty Partners, which may provide the company up to $65 million in non-dilutive funding to support ongoing clinical development of Clearside's pipeline, and pursuant to which HealthCare Royalty Partners will receive all royalties and milestone payments due to Clearside from XIPERE and certain SCS Microinjector license agreements, subject to a cap of 2.5 times the total purchase price paid by HealthCare Royalty under the agreement. The cap may be increased under certain circumstances. In Tuesday morning trading, shares of Clearside have gained about 9% to $1.78. Wish that line about lending finds was a bit more definitive....
--B. Riley starts Hyperfine at Buy on 'innovative' MRI technology 07:39 HYPR --Chipotle price target raised to $1,708 from $1,503 at Deutsche Bank 07:41 CMG --Needham starts Glaukos at Buy, expects recent launches to drive share recovery ยป 07:31 GKOS
INSIDER ALERT**** Braze director buys $17M in common stock 20:57 BRZE In a regulatory filing, Braze disclosed that its director Douglas Pepper bought 488.6K shares of common stock on September 29th in a total transaction size of $17M. BUY BRZE- $36.35
Cramer last night told me his buddies would kill this rally. He said that all these downgrades would come out today.... well after Cramer reads Radio Savant (as he does) he'll spit up is coffee (just like Overnight) It's on.. It's different this time and we ---> ALL IN. Pushing the cash into the portfolio........ I won't be able to buy again after today!!!!